subject: UMLS:C3641620


subject: UMLS:C3641620

subject_name: lirilumab

object_name: acute biphenotypic leukemia

tested_intervention: unsure


subject: UMLS:C3641620

object_name: Infant Acute Biphenotypic Leukemia


subject: CHEBI:6047

subject_name: isoprothiolane

object_name: malaria


subject: PR:000016675


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: paroxysmal atrial fibrillation

tested_intervention: yes


subject: CHEBI:38545

object_name: Paroxysmal Atrial Fibrillation by ECG Finding


subject: UMLS:C4505505

object_name: diabetic neuropathy


subject: UNII:8M7EWM4FYE


subject: CHEBI:4975

subject_name: Famotidine

object_name: Upper gastrointestinal hemorrhage


subject: CHEBI:8768

subject_name: Rabeprazole


subject: PUBCHEM.COMPOUND:22227703

subject_name: Loteprednol etabonate

object_name: conjunctivitis


subject: PUBCHEM.COMPOUND:22227703

object_name: Conjunctivitis, CTCAE


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Oligometastatic malignant neoplasm


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: GTOPDB:10471

subject_name: zagotenemab

object_name: Alzheimer disease


subject: UNII:AY6V5E2GNX

subject_name: ZAGOTENEMAB


subject: UMLS:C5419331

subject_name: Zagotenemab


subject: CHEBI:78870

subject_name: sodium nitrite


subject: CHEBI:78870

object_name: acute respiratory distress syndrome


subject: CHEBI:78870

object_name: adult acute respiratory distress syndrome


subject: CHEBI:78870

object_name: respiratory failure


subject: CHEBI:78870

object_name: acute respiratory failure


subject: CHEBI:33364

subject_name: Platinum

object_name: Neck Carcinoma


subject: CHEBI:33364

object_name: head and neck neoplasm


subject: CHEBI:33364

object_name: head and neck cancer


subject: CHEMBL.COMPOUND:CHEMBL1235478

subject_name: PLATINUM


subject: CHEMBL.COMPOUND:CHEMBL1235478


subject: CHEMBL.COMPOUND:CHEMBL1235478


subject: UMLS:C1171558

subject_name: Platinum metallicum, platinum, Homeopathic preparation


subject: UMLS:C1171558


subject: UMLS:C1171558


subject: UMLS:C1815442

subject_name: Travatan Z

object_name: glaucoma


subject: UMLS:C1815442

object_name: Glaucoma, CTCAE


subject: CHEBI:6775

subject_name: Mesalazine

object_name: Colonic diverticula


subject: CHEBI:391960

subject_name: Darifenacin

object_name: Nocturia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Marginal zone lymphoma stage I


subject: CHEBI:4026

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:4026

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:4026

object_name: Marginal zone lymphoma stage III


subject: CHEBI:4026

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:4026

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:4026

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:4026

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:3219

subject_name: Bupropion

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:3219

object_name: Fatigue


subject: CHEBI:3219

object_name: end stage renal failure


subject: CHEBI:3219

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:21937662

subject_name: Isavuconazole

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:21937662

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: Non-Severe Aplastic Anemia


subject: UNII:U6148108DZ

object_name: influenza


subject: UMLS:C0939690

subject_name: Crotalidae Polyvalent immune Fab

object_name: Snake Bites


subject: UMLS:C0939690

object_name: Snake bite (morphologic abnormality)


subject: CHEBI:233413

subject_name: Denifanstat

object_name: castration-resistant prostate carcinoma


subject: MESH:C000717092


subject: UMLS:C5873676

subject_name: Zepbound

object_name: LONGEVITY 1


subject: UMLS:C4054250

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UNII:IC9O2HT1X1

object_name: liver cancer


subject: UNII:IC9O2HT1X1

object_name: liver neoplasm


subject: UNII:IC9O2HT1X1

object_name: Adult Liver Carcinoma


subject: UNII:IC9O2HT1X1

object_name: liver carcinoma


subject: CHEBI:8871

subject_name: Risperidone

object_name: vascular dementia


subject: CHEBI:8871

object_name: Alzheimer disease type 1


subject: PR:000010436

subject_name: melanoma antigen recognized by T-cells 1

object_name: skin melanoma


subject: UMLS:C2827521

subject_name: Montanide ISA 51 VG


subject: PUBCHEM.COMPOUND:146014907


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: UMLS:C4329606

subject_name: CTAG1 Antibody


subject: UniProtKB:P78358

subject_name: CTG1B_HUMAN Cancer/testis antigen 1 (sprot)


subject: PUBCHEM.COMPOUND:118224238

object_name: Metastatic Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:118224238

object_name: Metastatic Biliary Tract Carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Erosive esophagitis


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:DPT0O3T46P

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:71015

subject_name: perampanel hydrate

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:71015

object_name: amyotrophic lateral sclerosis


subject: CHEBI:71013

subject_name: Perampanel


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: Unspecified menopausal and postmenopausal disorder


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:66910

subject_name: Axitinib

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:66910

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:66910

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:66910

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:66910

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:66910

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:66910

object_name: Carcinoma of the prostate stage III


subject: CHEBI:66910

object_name: Stage III Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: chronic atrophic gastritis


subject: PUBCHEM.COMPOUND:5281767

object_name: Stomach cancer


subject: UMLS:C5854589

subject_name: Anti-latent TGF-beta1 Monoclonal Antibody RG6440


subject: UMLS:C5854589

object_name: gastric cancer


subject: UMLS:C5854589

object_name: non-small cell lung carcinoma


subject: UMLS:C5854589

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:63631

subject_name: Topiramate

object_name: heavy drinking


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:41423

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:41423

object_name: Non-small cell lung cancer recurrent


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: triple-negative breast carcinoma


subject: UNII:I031V2H011

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:686WJT9102

subject_name: TALOTREXIN AMMONIUM

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C2699886

subject_name: Talotrexin Ammonium


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: esophageal squamous cell carcinoma


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: periodontal disorder


subject: CHEBI:16796

subject_name: Melatonin


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: Drug Interactions


subject: CHEBI:145795


subject: CHEBI:8805

subject_name: Repaglinide


subject: CHEBI:27999

subject_name: Tolbutamide


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: perinatal necrotizing enterocolitis


subject: CHEBI:17650

object_name: necrotizing enterocolitis


subject: CHEBI:17650

object_name: Necrotizing Enterocolitis, AE


subject: UNII:T432289GYZ

subject_name: Sinecatechins


subject: UMLS:C1434448

object_name: Childhood Anaplastic Oligodendroglioma


subject: UMLS:C1434448

object_name: anaplastic oligodendroglioma


subject: UMLS:C1434448

object_name: Adult Anaplastic Oligodendroglioma


subject: GTOPDB:8997

subject_name: ligelizumab

object_name: cold urticaria


subject: GTOPDB:8997

object_name: cholinergic urticaria


subject: UNII:L8LE0L691T


subject: UNII:L8LE0L691T


subject: UMLS:C4041919


subject: UMLS:C4041919


subject: UMLS:C2933414

object_name: metastatic colorectal cancer


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Chromosome 17p Deletion Syndrome


subject: UNII:4Z63YK6E0E

object_name: Smith-Magenis syndrome


subject: UNII:4Z63YK6E0E

object_name: chromosome 17p deletion


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Condyloma anal


subject: CHEBI:46195

object_name: anus disorder


subject: CHEBI:46195

object_name: Anal fissure


subject: CHEBI:46195

object_name: anal fistula


subject: CHEBI:46195

object_name: Rectal Fistula, CTCAE


subject: CHEBI:46195

object_name: Rectal fistula


subject: CHEBI:46195

object_name: hemorrhoid


subject: CHEBI:46195

object_name: Hemorrhoids, CTCAE 3.0


subject: CHEBI:46195

object_name: Hemorrhoids, CTCAE 5.0


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:36467

subject_name: Ciguatoxins


subject: CHEBI:204928

subject_name: Cefotaxime


subject: UMLS:C5574748

subject_name: C-Terminal Telopeptide Type 1 Collagen, human


subject: UMLS:C0010377

subject_name: Crotoxin


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Stage III renal cell cancer


subject: DRUGBANK:DB16369

subject_name: Matrix-M

object_name: malaria


subject: DRUGBANK:DB16369

object_name: Infection


subject: DRUGBANK:DB16369

object_name: Infection of musculoskeletal system


subject: DRUGBANK:DB16369

object_name: parasitic infectious disease


subject: DRUGBANK:DB16369

object_name: vector-borne disease


subject: CHEBI:34945

object_name: inflammatory bowel disease


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: UNII:1CIV2UMO40

subject_name: Minnelide

object_name: pancreatic neoplasm


subject: UNII:1CIV2UMO40

object_name: exocrine pancreatic carcinoma


subject: UNII:1CIV2UMO40

object_name: malignant pancreatic neoplasm


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: respiratory system disorder


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol

object_name: coronary artery disorder


subject: UNII:CLH5FT6412

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:53630253

object_name: neoplasm


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: lung cancer


subject: UNII:GKF8S4C432

object_name: lung carcinoma


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: Metastatic urothelial carcinoma


subject: UMLS:C1948073


subject: CHEBI:229764

subject_name: Selinexor

object_name: diffuse large B-cell lymphoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: malignant neoplasm of ovary stage IIIc


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:QEN1X95CIX

object_name: Ovarian cancer stage IV


subject: UNII:QEN1X95CIX

object_name: malignant neoplasm of ovary stage IV


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C3853844

object_name: endometrial cancer


subject: UMLS:C3853844

object_name: uterine corpus cancer


subject: UMLS:C3853844

object_name: endometrial carcinoma


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:9831414

object_name: Diabetes


subject: PUBCHEM.COMPOUND:9831414

object_name: diabetes mellitus


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: CHEBI:53785

subject_name: alverine citrate

object_name: irritable bowel syndrome


subject: CHEBI:518413

subject_name: Alverine


subject: CHEMBL.COMPOUND:CHEMBL2108741

subject_name: SIMETICONE


subject: CHEBI:29979

subject_name: L-histidine residue

object_name: Alzheimer disease type 1


subject: CHEBI:29979

object_name: Alzheimer disease


subject: CHEBI:15971

subject_name: Histidine


subject: CHEBI:15971


subject: UMLS:C0065461

subject_name: Maalox

object_name: HIV infection


subject: UNII:CVN0S9V910

subject_name: MAL


subject: CHEBI:15595


subject: UMLS:C4054906

subject_name: Gallium Ga 68-NOTA-AE105

object_name: Neck Carcinoma


subject: UMLS:C4054906

object_name: head and neck neoplasm


subject: UMLS:C4054906

object_name: head and neck cancer


subject: DRUGBANK:DB17279

subject_name: Anti-CD5 CAR T-cell therapy

object_name: T-Cell Lymphoma


subject: DRUGBANK:DB17279

object_name: Pre T-ALL


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: non-ischemic central retinal vein occlusion with macular edema


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab


subject: CHEBI:72296

subject_name: Apixaban

object_name: Rest limb pain


subject: CHEBI:231678

subject_name: Evofosfamide

object_name: metastatic melanoma


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: paroxysmal nocturnal hemoglobinuria


subject: UNII:3A189DH42V

object_name: juvenile myelomonocytic leukemia


subject: UNII:3A189DH42V

object_name: Leukemia - chronic myeloid leukemia (CML)


subject: UNII:3A189DH42V

object_name: adult acute myeloid leukemia


subject: UNII:3A189DH42V

object_name: Leukemia - acute myeloid leukemia (AML)


subject: UNII:3A189DH42V

object_name: childhood acute myeloid leukemia


subject: UNII:3A189DH42V

object_name: acute myeloid leukemia


subject: UNII:3A189DH42V

object_name: Adult Hodgkin Lymphoma


subject: UNII:3A189DH42V

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UMLS:C0003442


subject: UMLS:C1446777

subject_name: Rabbit antigen


subject: UMLS:C1446777


subject: UMLS:C1446777

object_name: acute lymphoblastic leukemia


subject: UMLS:C1446777

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C1446777


subject: UMLS:C1446777


subject: UMLS:C1446777


subject: UMLS:C1446777


subject: UMLS:C1446777

object_name: Hodgkin Disease


subject: UMLS:C1446777


subject: UMLS:C1446777


subject: UMLS:C2093603

subject_name: Rabbit


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: UNII:JGA39ICE2V

subject_name: Muromonab


subject: UNII:JGA39ICE2V

object_name: Myelodysplasia


subject: UNII:JGA39ICE2V


subject: UNII:JGA39ICE2V


subject: UNII:JGA39ICE2V


subject: UNII:JGA39ICE2V


subject: UNII:JGA39ICE2V


subject: UNII:JGA39ICE2V


subject: UNII:JGA39ICE2V


subject: UNII:JGA39ICE2V


subject: UNII:JGA39ICE2V


subject: UNII:JGA39ICE2V


subject: UNII:JGA39ICE2V


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Stage IB Pleural Malignant Mesothelioma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage II Pleural Malignant Mesothelioma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IA Pleural Malignant Mesothelioma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Mesothelioma malignant recurrent


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Pleural Malignant Mesothelioma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: malignant epithelioid mesothelioma


subject: PUBCHEM.COMPOUND:131769963

object_name: sarcomatoid mesothelioma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: UMLS:C5447493

subject_name: PI3Kdelta/gamma Inhibitor ZX-101A

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5447493

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C5447493

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form

object_name: Pharyngocutaneous fistula


subject: UNII:C4V974V932

object_name: squamous cell carcinoma


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green


subject: PUBCHEM.COMPOUND:6096882


subject: PUBCHEM.COMPOUND:44567960

subject_name: VASOACTIVE INTESTINAL PEPTIDE

object_name: Chronic obstructive pulmonary disease of horses


subject: PUBCHEM.COMPOUND:44567960

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:44567960

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:44567960

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:44567960

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:80331

subject_name: Vasoactive intestinal peptide


subject: CHEBI:80331


subject: CHEBI:80331


subject: CHEBI:80331


subject: CHEBI:80331


subject: UMLS:C0042395

subject_name: vasoactive intestinal peptide


subject: UMLS:C0042395


subject: UMLS:C0042395


subject: UMLS:C0042395


subject: UMLS:C0042395


subject: PUBCHEM.COMPOUND:16129679

subject_name: VIP


subject: PUBCHEM.COMPOUND:16129679


subject: PUBCHEM.COMPOUND:16129679


subject: PUBCHEM.COMPOUND:16129679


subject: PUBCHEM.COMPOUND:16129679


subject: PUBCHEM.COMPOUND:70691420

subject_name: Aviptadil


subject: PUBCHEM.COMPOUND:70691420


subject: PUBCHEM.COMPOUND:70691420


subject: PUBCHEM.COMPOUND:70691420


subject: PUBCHEM.COMPOUND:70691420


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: psoriasis


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: diabetic peripheral angiopathy


subject: CHEBI:3614

object_name: age-related macular degeneration


subject: CHEBI:3614

object_name: Proliferative retinopathy


subject: CHEBI:3614

object_name: retinal vein occlusion


subject: UNII:KXQ762CQTH

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:KXQ762CQTH

object_name: Adult Soft Tissue Sarcoma


subject: UNII:KXQ762CQTH

object_name: sarcoma


subject: UNII:KXQ762CQTH

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:KXQ762CQTH

object_name: soft tissue sarcoma


subject: UNII:KXQ762CQTH

object_name: metastatic neoplasm


subject: UNII:KXQ762CQTH

object_name: Metastatic Lesion


subject: UNII:J6U9WP10T7


subject: UNII:J6U9WP10T7


subject: UNII:J6U9WP10T7


subject: UNII:J6U9WP10T7


subject: UNII:J6U9WP10T7


subject: UNII:J6U9WP10T7


subject: UNII:J6U9WP10T7


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: sudden sensorineural hearing loss


subject: MESH:D007166

subject_name: Immunosuppressive Agents

object_name: transplantation infection


subject: MESH:D007166

object_name: complications; renal, allograft


subject: PUBCHEM.COMPOUND:3298

subject_name: Eicosapentaenoic acid ethyl ester

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:3298

object_name: Upper Respiratory Infections


subject: PUBCHEM.COMPOUND:3298

object_name: respiratory tract infectious disorder


subject: PUBCHEM.COMPOUND:3298

object_name: Recurrent upper respiratory tract infections


subject: CHEBI:84883

subject_name: Icosapent ethyl


subject: CHEBI:84883


subject: CHEBI:84883


subject: UMLS:C5206828

subject_name: Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP

object_name: Lynch syndrome


subject: UMLS:C5206828

object_name: Hereditary Nonpolyposis Colorectal Cancer


subject: UMLS:C5206828

object_name: colorectal carcinoma


subject: UMLS:C5206829

subject_name: MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP


subject: UMLS:C5206829


subject: UMLS:C5206829


subject: CHEBI:145924

subject_name: Kaletra

object_name: AIDS


subject: CHEBI:31781

subject_name: Lopinavir


subject: RXCUI:284756


subject: UMLS:C0013227


subject: UMLS:C1254351


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: psychosis


subject: UMLS:C1527137

object_name: Psychotic disorder due to a general medical condition


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:82339

subject_name: Merphalan

object_name: colorectal cancer


subject: CHEBI:82339


subject: CHEBI:82339

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:82339

object_name: appendix cancer


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:52717

subject_name: Bortezomib

object_name: transitional cell carcinoma


subject: CHEBI:52717

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:52717

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: CHEBI:52717

object_name: Stage III Urethral Cancer AJCC v8


subject: CHEBI:52717

object_name: Stage III Urethral Cancer AJCC v7


subject: CHEBI:52717

object_name: Recurrent Urethral Cancer


subject: CHEBI:52717

object_name: Stage IV Urethral Cancer AJCC v8


subject: CHEBI:52717

object_name: Stage IV Urethral Cancer AJCC v7


subject: CHEBI:52717

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: CHEBI:52717

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:52717

object_name: Bladder cancer recurrent


subject: CHEBI:52717

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:52717

object_name: Stage IV Bladder Cancer AJCC v7


subject: CHEBI:52717

object_name: Bladder cancer stage IV


subject: CHEBI:52717

object_name: Stage IV Bladder Cancer AJCC v6


subject: CHEBI:52717

object_name: ureter cancer


subject: CHEBI:52717

object_name: ureter carcinoma


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: masticatory muscles, hypertrophy of


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Intestinal bacteria flora disturbance


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:5181

subject_name: fucoidan

object_name: Helicobacter pylori infection


subject: CHEBI:5181


subject: CHEBI:27470

subject_name: Folic acid

object_name: transient ischemic attack


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: cerebrovascular disorder


subject: CHEBI:28911

object_name: Stroke (heart beat)


subject: CHEBI:28911

object_name: Stroke, CTCAE


subject: CHEBI:28911


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:231342

subject_name: ceralasertib

object_name: High grade serous carcinoma


subject: UMLS:C3827158


subject: CHEBI:83766

subject_name: Olaparib


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Dyslipidemia


subject: CHEBI:135919

subject_name: Nesiritide

object_name: Renal dysfunction


subject: CHEBI:16348

subject_name: Bovinocidin

object_name: kidney failure


subject: CHEBI:16348


subject: CHEBI:16348

object_name: heart failure


subject: CHEBI:16348

object_name: Heart Failure, CTCAE


subject: CHEBI:80234

subject_name: Brain natriuretic peptide


subject: CHEBI:80234


subject: CHEBI:80234


subject: CHEBI:80234


subject: CHEBI:10100

subject_name: Zafirlukast

object_name: Childhood Breast Carcinoma


subject: CHEBI:10100

object_name: breast carcinoma


subject: CHEBI:10100

object_name: breast cancer


subject: CHEBI:231324

subject_name: alpelisib

object_name: colorectal cancer


subject: CHEBI:231324

object_name: colorectal carcinoma


subject: CHEBI:231324

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2986399


subject: UMLS:C2986399


subject: UMLS:C2986399


subject: UMLS:C3273936


subject: UMLS:C3273936


subject: UMLS:C3273936


subject: UNII:V5Y646AW8S

object_name: Minimally Conscious State


subject: UNII:V5Y646AW8S

object_name: Coma


subject: UNII:V5Y646AW8S

object_name: ocular motor apraxia, Cogan type


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:6538

object_name: brain injury


subject: CHEBI:6538


subject: CHEBI:6538

object_name: traumatic encephalopathy


subject: CHEBI:6538

object_name: traumatic brain injury


subject: CHEBI:6538


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: Locally Advanced Pancreatic Ductal Adenocarcinoma


subject: UMLS:C3898831

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C3898831

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:134964

subject_name: Perflubutane

object_name: Cardiac catheterisation as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure


subject: CHEBI:134964

object_name: Blood Pressure Finding


subject: CHEBI:134964

object_name: Systemic arterial pressure


subject: CHEBI:134964

object_name: heart failure


subject: CHEBI:134964

object_name: Heart Failure, CTCAE


subject: MESH:C069727

subject_name: Sonazoid


subject: MESH:C069727


subject: MESH:C069727


subject: MESH:C069727


subject: MESH:C069727


subject: PUBCHEM.COMPOUND:21873174

subject_name: Testosterone undecanoate

object_name: spinal cord injury


subject: CHEBI:145421

subject_name: rigosertib sodium

object_name: cancer


subject: CHEBI:145421

object_name: neoplasm


subject: CHEBI:145421

object_name: Advanced cancer


subject: UMLS:C4317276

object_name: Solid Neoplasm


subject: UMLS:C4317276


subject: UMLS:C4317276


subject: UMLS:C4317276


subject: CHEBI:31348

subject_name: Capecitabine

object_name: periampullary adenocarcinoma


subject: CHEBI:45716

subject_name: Vorinostat


subject: UMLS:C3864383

subject_name: Lumason

object_name: vesicoureteral reflux


subject: CHEBI:28645

subject_name: FRUCTOSE

object_name: Fatty Liver


subject: CHEBI:28645


subject: CHEBI:48095

subject_name: keto-D-fructose


subject: CHEBI:48095


subject: CHEBI:17925

subject_name: alpha-D-glucose


subject: CHEBI:17925


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: UMLS:C1161331

subject_name: Saccharum officinale, sucrose, cane sugar, Homeopathic preparation


subject: UMLS:C1161331


subject: CHEBI:17992

subject_name: Sucrose


subject: CHEBI:17992


subject: PR:000002327

subject_name: gelsolin isoform 1

object_name: HIV infection


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: habitual spontaneous abortion


subject: UNII:S276568KOY

subject_name: Gadopiclenol

object_name: Blood brain barrier defect


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026

object_name: adult pure red cell aplasia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6

object_name: Severe Aplastic Anemia


subject: UNII:4F4X42SYQ6

object_name: severe aplastic anemia


subject: UNII:4F4X42SYQ6

object_name: paroxysmal nocturnal hemoglobinuria


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61057

object_name: Duchenne muscular dystrophy


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049


subject: CHEBI:8988

object_name: Mismatch Repair Proficient


subject: CHEBI:8988

object_name: Microsatellite Stable


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:124939

subject_name: Rigosertib

object_name: acute lymphoblastic leukemia


subject: CHEBI:124939

object_name: acute myeloid leukemia


subject: CHEBI:124939

object_name: myeloproliferative neoplasm


subject: CHEBI:124939

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: DRUGBANK:DB10516

subject_name: Casein

object_name: sarcopenia


subject: UMLS:C0026138

subject_name: Milk Proteins


subject: UMLS:C1446647

subject_name: Milk antigen


subject: DRUGBANK:DB10543

subject_name: Cow milk


subject: UMLS:C0444318

subject_name: Milk Specimen


subject: UMLS:C3535674

subject_name: Pea Proteins


subject: CHEBI:6801

subject_name: Metformin

object_name: pediatric osteosarcoma


subject: CHEBI:6801

object_name: Osteosarcoma


subject: CHEBI:6801

object_name: Ewing sarcoma


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C1706792

object_name: adult lymphoma


subject: UMLS:C1706792

object_name: lymphoma


subject: UMLS:C1706792

object_name: pediatric lymphoma


subject: DRUGBANK:DB18667


subject: CHEBI:4653

subject_name: Dipyridamole

object_name: pancreatic neoplasm


subject: CHEBI:4653

object_name: exocrine pancreatic carcinoma


subject: CHEBI:4653

object_name: malignant pancreatic neoplasm


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Burn injury


subject: UMLS:C0169964

subject_name: somatropin


subject: CHEBI:48299

subject_name: Erythritol

object_name: Emotional state observations


subject: PUBCHEM.COMPOUND:5066234

subject_name: Sucralose


subject: UMLS:C1161331

subject_name: Saccharum officinale, sucrose, cane sugar, Homeopathic preparation


subject: CHEBI:17992

subject_name: Sucrose


subject: CHEBI:30742

subject_name: macrogol

object_name: Surgical procedure finding


subject: PR:000012224

subject_name: glycodelin


subject: PUBCHEM.COMPOUND:56841751

subject_name: Epidermal Growth Factor

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:56841751


subject: PUBCHEM.COMPOUND:56841751


subject: PUBCHEM.COMPOUND:56841751


subject: PR:000006928

subject_name: pre-pro-epidermal growth factor


subject: PR:000006928


subject: PR:000006928


subject: PR:000006928


subject: PR:000060269

subject_name: epidermal growth factor


subject: PR:000060269


subject: PR:000060269


subject: PR:000060269


subject: CHEBI:140739

subject_name: Glu-Gly-Phe


subject: CHEBI:140739


subject: CHEBI:140739


subject: CHEBI:140739


subject: GTOPDB:4916

subject_name: EGF


subject: GTOPDB:4916


subject: GTOPDB:4916


subject: GTOPDB:4916


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: cystic fibrosis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C5205393

subject_name: Reozalimab

object_name: Advanced cancer


subject: CHEBI:6801

subject_name: Metformin

object_name: Vaccine response impaired


subject: CHEBI:6801

object_name: Age-related immunodeficiency


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: Acute Pain


subject: UMLS:C0360094

object_name: sickle cell disease


subject: UMLS:C0360094

object_name: Vaso-Occlusive Crisis


subject: UMLS:C0360094

object_name: Hemoglobin SS disease with crisis


subject: CHEBI:174615

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: CHEBI:174615

object_name: acute myeloid leukemia, t(3;5)(q25;q34)


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:94265

subject_name: Cerubidin

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:94265


subject: CHEBI:94265

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:94265


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: CD22 Positive


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: CD19 Positive


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:26708

subject_name: sodium atom

object_name: type 2 diabetes mellitus


subject: CHEBI:29101

subject_name: Sodium cation


subject: UMLS:C3541959

subject_name: Sodium supplements


subject: UMLS:C3714642

subject_name: Sodium Drug Class


subject: UMLS:C0591295

subject_name: corsodyl

object_name: Dental Plaque


subject: UMLS:C0591295

object_name: periodontal disorder


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: pneumonitis


subject: HMDB:HMDB0013470

object_name: pneumonia


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:89981


subject: CHEBI:36939

subject_name: Fluorine F-18


subject: CHEBI:36939


subject: UNII:R1W11H9AUK

subject_name: NOS


subject: UNII:R1W11H9AUK


subject: CHEBI:6801

subject_name: Metformin

object_name: bladder tumor


subject: CHEBI:6801

object_name: urinary bladder carcinoma


subject: CHEBI:6801

object_name: urinary bladder cancer


subject: CHEBI:6801

object_name: childhood bladder carcinoma


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:9150


subject: CHEBI:9150


subject: CHEBI:9150


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Shock


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:5466794

object_name: Pancreatic carcinoma stage II


subject: PUBCHEM.COMPOUND:5466794

object_name: Stage II Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:5466794

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:5466794

object_name: stage IV pancreatic cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:5466794

object_name: Pancreatic carcinoma recurrent


subject: PUBCHEM.COMPOUND:5466794

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:5466794

object_name: Pancreatic carcinoma stage III


subject: PUBCHEM.COMPOUND:5466794

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:5466794

object_name: pancreatic adenocarcinoma


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: atopic eczema


subject: CHEBI:9667

object_name: dermatitis


subject: CHEBI:9667

object_name: Eczema, CTCAE


subject: CHEBI:53498

subject_name: triacetylcellulose


subject: CHEBI:53498


subject: CHEBI:53498


subject: UMLS:C2962221

subject_name: TAC


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: plasma cell myeloma


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Hypoxemia


subject: CHEBI:3441

object_name: Hypoxia, CTCAE


subject: CHEBI:64019

subject_name: Nebivolol


subject: CHEBI:64019


subject: PR:000007515

subject_name: four and a half LIM domains protein 5

object_name: Plasmodium falciparum malaria


subject: PR:000014683


subject: PR:000023516

subject_name: pyruvate formate-lyase 1-activating enzyme


subject: UniProtKB:P0A9N4

subject_name: PFLA_ECOLI Pyruvate formate-lyase 1-activating enzyme (sprot)


subject: CHEBI:9635

subject_name: Toremifene

object_name: fibromatosis


subject: CHEBI:9635

object_name: desmoid tumor


subject: CHEBI:9635

object_name: Desmoid tumor


subject: CHEBI:62881

subject_name: Riboprine

object_name: Nausea, CTCAE_5


subject: CHEBI:62881

object_name: Nausea


subject: CHEBI:62881

object_name: Nausea, CTCAE_3


subject: CHEBI:29750

subject_name: Indolepyruvate


subject: CHEBI:29750


subject: CHEBI:29750


subject: CHEBI:43580

subject_name: Indolepropionic acid


subject: CHEBI:43580


subject: CHEBI:43580


subject: CHEBI:30802

subject_name: isophthalate


subject: CHEBI:30802


subject: CHEBI:30802


subject: CHEBI:28364

subject_name: Icosapent


subject: CHEBI:28364


subject: CHEBI:28364


subject: UMLS:C3828882

subject_name: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C3828882

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C3828882

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3828882

object_name: acute myeloid leukemia


subject: UNII:Y1WPQ66L9G

subject_name: SODIUM ACETATE C 11

object_name: prostate carcinoma


subject: UNII:Y1WPQ66L9G

object_name: prostate cancer


subject: UNII:TA3QN7788D

object_name: high grade B-cell lymphoma


subject: UNII:TA3QN7788D

object_name: diffuse large B-cell lymphoma


subject: UNII:TA3QN7788D

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:TA3QN7788D

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: HIV infection


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor

object_name: infertility


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Bladder transitional cell carcinoma stage IV


subject: CHEBI:45863

object_name: Urothelial carcinoma bladder recurrent


subject: PUBCHEM.COMPOUND:4490623

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:9506

subject_name: tetrodotoxin


subject: CHEBI:180459


subject: CHEBI:4445

subject_name: Desflurane

object_name: adverse effect to anesthesia


subject: CHEBI:4445

object_name: Congenital abnormality of respiratory system


subject: CHEBI:40279

subject_name: Allopurinol

object_name: diabetic kidney disease


subject: GTOPDB:8221

subject_name: epacadostat

object_name: Disseminated Malignant Neoplasm


subject: GTOPDB:8221

object_name: Embolism, Tumor


subject: GTOPDB:8221

object_name: Neoplasm Metastasis


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:87TZD0JEBS

object_name: Solid Neoplasm


subject: UNII:87TZD0JEBS


subject: UNII:87TZD0JEBS


subject: UNII:87TZD0JEBS


subject: MESH:C000730036


subject: MESH:C000730036


subject: MESH:C000730036


subject: MESH:C000730036


subject: UNII:VUW370O5QE

subject_name: Cancidas

object_name: cancer


subject: UNII:VUW370O5QE

object_name: neoplasm


subject: PUBCHEM.COMPOUND:3035406

subject_name: Caspofungin


subject: PUBCHEM.COMPOUND:3035406


subject: UMLS:C1145191

subject_name: INJECTION, CASPOFUNGIN ACETATE, 5 MG


subject: UMLS:C1145191


subject: UMLS:C0935942


subject: UMLS:C0935942


subject: UMLS:C0962969

subject_name: RAD 001

object_name: glioma


subject: UMLS:C0962969

object_name: malignant glioma


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Prostatic Infection


subject: CHEBI:100241

object_name: Prostate Infection, CTCAE


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:45924


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: CHEBI:71464

subject_name: Palmidrol

object_name: osteoarthritis, knee


subject: UMLS:C1144384

subject_name: G-3139 oligonucleotide


subject: UMLS:C1258613

subject_name: oblimersen sodium


subject: CHEBI:51041

subject_name: Acamprosate

object_name: Parkinson disease


subject: UNII:1RXS4UE564

subject_name: Alteplase

object_name: Pulmonary thromboembolism


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: vulvodynia


subject: CHEBI:197437

subject_name: Mocetinostat

object_name: adult lymphoma


subject: CHEBI:197437

object_name: lymphoma


subject: CHEBI:197437

object_name: pediatric lymphoma


subject: UMLS:C4048878

subject_name: MGCD 0103


subject: UMLS:C4048878


subject: UMLS:C4048878


subject: CHEBI:35745

object_name: Glue ear


subject: CHEBI:35745

object_name: tympanic membrane perforation


subject: CHEBI:35745

object_name: infectious otitis media


subject: CHEBI:35745

object_name: Acute otitis media


subject: CHEBI:35745

object_name: pneumococcal infection


subject: CHEBI:35739

subject_name: Pentetic acid


subject: CHEBI:35739


subject: CHEBI:35739


subject: CHEBI:35739


subject: CHEBI:35739


subject: UMLS:C0071315

subject_name: Pneumovax


subject: UMLS:C0071315


subject: UMLS:C0071315


subject: UMLS:C0071315


subject: MESH:C505143

subject_name: Boostrix


subject: MESH:C505143


subject: MESH:C505143


subject: MESH:C505143


subject: MESH:C505143


subject: CHEBI:35341

subject_name: steroid

object_name: Headache


subject: CHEBI:35341

object_name: Headache, CTCAE


subject: CHEBI:35341

object_name: rheumatoid arthritis


subject: UMLS:C4719865

subject_name: Montelukast Sodium Tablets

object_name: Atopic rhinitis


subject: UMLS:C4719865

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Breast cancer recurrent


subject: CHEBI:3441

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:3441

object_name: HER2 positive


subject: CHEBI:3441

object_name: metastatic malignant neoplasm in the brain


subject: UNII:98DE7VN88D

subject_name: huMov 19

object_name: endometrial cancer


subject: UNII:98DE7VN88D

object_name: uterine corpus cancer


subject: UNII:98DE7VN88D

object_name: endometrial carcinoma


subject: UNII:98DE7VN88D

object_name: endometrium adenocarcinoma


subject: UNII:98DE7VN88D

object_name: endometrial clear cell adenocarcinoma


subject: UNII:98DE7VN88D

object_name: endometrial serous adenocarcinoma


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: CHEBI:24848

subject_name: inositol

object_name: Hair-pulling


subject: CHEBI:84363

object_name: Cognitive impairment


subject: CHEBI:2376

subject_name: acarbose


subject: CHEBI:85078

subject_name: Dapagliflozin


subject: CHEBI:16118

subject_name: Berberine

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:16118

object_name: Abdominal obesity


subject: CHEBI:4604

subject_name: dimenhydrinate

object_name: dizziness


subject: CHEBI:4604

object_name: Vertigo as late effect of cerebrovascular disease


subject: CHEBI:4604

object_name: Vertigo, CTCAE


subject: CHEBI:4604

object_name: Nausea, CTCAE_5


subject: CHEBI:4604

object_name: Nausea


subject: CHEBI:4604

object_name: Nausea, CTCAE_3


subject: CHEBI:4604

object_name: Vomiting, CTCAE


subject: CHEBI:4604

object_name: Vomiting


subject: CHEBI:107736

subject_name: Metoclopramide


subject: CHEBI:107736


subject: CHEBI:107736


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: anxiety


subject: CHEBI:6950

object_name: Anxiety symptoms


subject: CHEBI:6950

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:6950

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:6950

object_name: Parkinson disease


subject: UMLS:C2240391

subject_name: Herbal medicine (product)

object_name: rotator cuff syndrome


subject: UMLS:C2240391

object_name: Rotator cuff tear


subject: CHEBI:64317

subject_name: Isoprenaline

object_name: Tachycardia by ECG Finding


subject: CHEBI:64317

object_name: Tachycardia


subject: CHEBI:64317

object_name: Irritable heart


subject: CHEBI:64317

object_name: autonomic nervous system disorder


subject: CHEBI:64317

object_name: primary dysautonomia


subject: CHEBI:64317

object_name: dysautonomia


subject: CHEBI:64317

object_name: Arrhythmia


subject: CHEBI:64317

object_name: cardiovascular disorder


subject: CHEBI:64317

object_name: neurocirculatory asthenia


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8093


subject: UNII:63V8AIE65T

object_name: IDH-wildtype glioblastoma


subject: UNII:63V8AIE65T

object_name: MGMT-Unmethylated Glioblastoma


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)

object_name: cocaine dependence


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313

object_name: Post-polycythemia vera myelofibrosis


subject: GTOPDB:8313

object_name: juvenile myelomonocytic leukemia


subject: GTOPDB:8313

object_name: chronic myelomonocytic leukemia


subject: GTOPDB:8313

object_name: essential thrombocythemia


subject: GTOPDB:8313

object_name: acquired polycythemia vera


subject: GTOPDB:8313

object_name: myelofibrosis


subject: CHEBI:231350

subject_name: Pacritinib


subject: CHEBI:36080

subject_name: protein

object_name: malnutrition


subject: UMLS:C0033684

subject_name: Proteins


subject: PR:000000001


subject: CHEBI:16646

subject_name: carbohydrate


subject: UMLS:C0147919

subject_name: uro-vaxom

object_name: Antibiotic Resistance, Microbial


subject: UMLS:C0147919

object_name: cauda equina syndrome with neurogenic bladder


subject: UMLS:C0147919

object_name: Neurogenic bladder


subject: UMLS:C0147919

object_name: urinary tract infection


subject: UMLS:C0147919

object_name: bacterial urinary tract infection


subject: CHEBI:5558

subject_name: Guanfacine

object_name: Alzheimer disease type 1


subject: CHEBI:5558

object_name: Alzheimer disease


subject: CHEBI:2668

subject_name: Amlodipine

object_name: Isolated systolic hypertension


subject: RXCUI:1049221

subject_name: acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet

object_name: Post-Operative Pain


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:37941

object_name: COPD, severe early onset


subject: CHEBI:37941

object_name: chronic obstructive pulmonary disease


subject: CHEBI:37941

object_name: Acute exacerbation of chronic obstructive pulmonary disease


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Mental deterioration


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Cognitive impairment


subject: CHEBI:58097

object_name: hepatobiliary disorder


subject: CHEBI:58097

object_name: liver disorder


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEMBL.COMPOUND:CHEMBL5314341

subject_name: GLUCAGON


subject: CHEMBL.COMPOUND:CHEMBL5314341


subject: CHEBI:5391

subject_name: Glucagon


subject: CHEBI:5391


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: Head and neck cancers - salivary gland


subject: UMLS:C3489751

object_name: rheumatoid arthritis


subject: CHEBI:91899

object_name: Extreme immaturity


subject: CHEBI:3207

subject_name: Budesonide


subject: UMLS:C5445196

subject_name: Oxaliplatin Liquid Injection


subject: UMLS:C5445196

object_name: gastric adenocarcinoma


subject: CHEBI:3699

subject_name: Cimetidine

object_name: Finding of lactation


subject: UMLS:C1706415

subject_name: Interleukin-3 Receptor alpha Subunit

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C1706415

object_name: acute myeloid leukemia


subject: UMLS:C1706415

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C1706415

object_name: adult acute myeloid leukemia


subject: PR:000001865

subject_name: interleukin-3 receptor class 2 alpha chain


subject: PR:000001865


subject: PR:000001865


subject: PR:000001865


subject: CHEBI:49200

subject_name: EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor

object_name: Childhood Breast Carcinoma


subject: CHEBI:49200

object_name: breast carcinoma


subject: CHEBI:49200

object_name: breast cancer


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: UMLS:C0358591


subject: UMLS:C0358591


subject: UMLS:C3536754

subject_name: Proton Pump Inhibitor [EPC]


subject: UMLS:C3536754


subject: UMLS:C3536754


subject: CHEBI:195558

subject_name: Entrectinib

object_name: uveal melanoma


subject: CHEBI:231696


subject: PR:000006746

subject_name: dual specificity protein phosphatase 2


subject: PR:000013397

subject_name: proteasome assembly chaperone 1


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: prostate cancer


subject: CHEBI:27812


subject: CHEBI:27812


subject: CHEBI:27812


subject: CHEBI:85989

subject_name: Avycaz

object_name: Complicated intra-abdominal infection


subject: UMLS:C3656596

subject_name: avibactam / ceftazidime


subject: CHEBI:6427

subject_name: Leuprolide

object_name: hypogonadotropic hypogonadism


subject: CHEBI:6427

object_name: Klinefelter syndrome


subject: UMLS:C4725098

subject_name: HAAH Lambda phage Vaccine SNS-301

object_name: Myelodysplasia


subject: UMLS:C4725098

object_name: chronic myelomonocytic leukemia


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: yellow skin or eyes (symptom)


subject: UNII:T42P99266K

object_name: jaundice


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: UNII:77AP23J0GH

object_name: Drug Interactions


subject: CHEBI:3732

subject_name: Clarithromycin


subject: UMLS:C0304229

subject_name: Experimental drug

object_name: Metastatic malignant neoplasm to liver


subject: UMLS:C0304229

object_name: colorectal cancer


subject: UMLS:C0304229

object_name: colorectal carcinoma


subject: UMLS:C0304229

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:73609

subject_name: Met-Ala-Asp

object_name: postherpetic neuralgia


subject: CHEBI:73609

object_name: diabetic neuropathy


subject: CHEBI:73609

object_name: neuralgia


subject: CHEBI:73609

object_name: Neuropathic pain


subject: MESH:C110804

subject_name: mycophenolic adenine dinucleotide


subject: MESH:C110804


subject: MESH:C110804


subject: MESH:C110804


subject: UMLS:C4508324

object_name: Gender


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Neuromuscular scoliosis


subject: CHEBI:41879

object_name: scoliosis, isolated, susceptibility to, 1


subject: CHEBI:73611

subject_name: Met-Gly

object_name: Musculoskeletal Pain


subject: CHEBI:25107

subject_name: magnesium atom


subject: PR:000004501

subject_name: attractin


subject: UMLS:C0487173

subject_name: Mg antigen


subject: PUBCHEM.COMPOUND:92002593

subject_name: Ibritumomab

object_name: marginal zone lymphoma


subject: PUBCHEM.COMPOUND:92002593

object_name: MALT lymphoma


subject: UNII:4Q52C550XK

subject_name: Ibritumomab tiuxetan


subject: UNII:4Q52C550XK


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: Graft Rejection


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate

object_name: respiratory tract infectious disorder


subject: CHEBI:33353

subject_name: technetium atom

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:33353

object_name: rhabdomyosarcoma


subject: CHEBI:33353

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:33353

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: acute myeloid leukemia with 11q23 abnormalities


subject: PUBCHEM.COMPOUND:596

object_name: acute myeloid leukemia, MLL gene rearrangement


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:94265


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:64677


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: PUBCHEM.COMPOUND:132212657

subject_name: Revumenib

object_name: acute myeloid leukemia with mutated NPM1


subject: PUBCHEM.COMPOUND:132212657


subject: PUBCHEM.COMPOUND:132212657


subject: PUBCHEM.COMPOUND:169490859

subject_name: Revumenib citrate


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: MESH:D000082082

object_name: Metastatic non-small cell lung cancer


subject: MESH:D000082082

object_name: childhood neoplasm


subject: MESH:D000082082

object_name: neoplastic syndrome


subject: MESH:D000082082

object_name: cancer or benign tumor


subject: UMLS:C5435306

object_name: acute kidney failure


subject: UMLS:C5435306

object_name: Acute Kidney Injury, CTCAE


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin

object_name: type 1 diabetes mellitus 1


subject: PUBCHEM.COMPOUND:74323022

object_name: type 1 diabetes mellitus


subject: CHEBI:50730

subject_name: Montelukast

object_name: Food-Drug Interactions


subject: UNII:3G30P7ME1J

subject_name: RIFERMINOGENE PECAPLASMID

object_name: peripheral vascular disease


subject: CHEBI:5441

subject_name: Glyburide

object_name: Arterial Stiffness


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: CHEBI:40237

subject_name: Sitagliptin


subject: GTOPDB:7989

subject_name: sirukumab

object_name: polymyalgia rheumatica


subject: CHEMBL.COMPOUND:CHEMBL1743071

subject_name: SIRUKUMAB


subject: UMLS:C3254570


subject: UMLS:C0879595

subject_name: Selective Cytokine Inhibitory Drug CC-1088

object_name: leukemia


subject: UMLS:C0879595

object_name: childhood leukemia


subject: UMLS:C0020852

subject_name: immunoglobulin G

object_name: autoimmune encephalitis


subject: UMLS:C3536873

subject_name: Immunoglobulin G [EPC]


subject: GTOPDB:437

object_name: Myelodysplasia


subject: GTOPDB:437

object_name: Adult Myelodysplastic Syndrome


subject: GTOPDB:437

object_name: childhood myelodysplastic syndrome


subject: GTOPDB:437

object_name: Myelodysplastic Syndrome, CTCAE


subject: GTOPDB:437

object_name: acute myeloid leukemia by FAB classification


subject: GTOPDB:437

object_name: acute myeloid leukemia


subject: UMLS:C0950716


subject: UMLS:C0950716


subject: UMLS:C0950716


subject: UMLS:C0950716


subject: UMLS:C0950716


subject: UMLS:C0950716


subject: CHEBI:59773

subject_name: CROMOLYN

object_name: Alzheimer disease type 1


subject: CHEBI:59773

object_name: Alzheimer disease


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: DRUGBANK:DB19249

subject_name: Bos taurus colostrum

object_name: Enteral feeding intolerance


subject: UMLS:C0206492

subject_name: Antibodies, Bispecific

object_name: cancer


subject: UMLS:C0206492

object_name: neoplasm


subject: MESH:D002800

subject_name: Cholinesterase Inhibitors

object_name: Lewy Bodies


subject: CHEBI:8874

subject_name: Rivastigmine


subject: CHEBI:145499

subject_name: Donepezil


subject: CHEBI:8364

subject_name: Prazosin

object_name: combat disorder


subject: MESH:C110747

subject_name: cyclopropapyrroloindole

object_name: HIV infection


subject: UNII:90ZX3Q3FR7

subject_name: Risankizumab

object_name: inflammatory bowel disease


subject: UMLS:C4078397


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: primary interstitial lung disease specific to childhood


subject: CHEBI:27306

subject_name: vitamin B6

object_name: atrial septal defect


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism


subject: UMLS:C3540792

object_name: autism spectrum disorder


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: UMLS:C0021735

subject_name: Viraferon


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:46245

object_name: Fatigue


subject: CHEBI:46245

object_name: Soreness


subject: CHEBI:46245

object_name: Asthenia


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: Overweight


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: malignant urinary system neoplasm


subject: UMLS:C3827082


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Bone marrow depression


subject: UMLS:C0003442

object_name: Bone marrow hypocellularity


subject: UMLS:C0003442

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C0003442

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C0770694

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C0770694

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: MESH:D007252


subject: MESH:D007252


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: UMLS:C5395271


subject: UMLS:C5395271


subject: UMLS:C5856418

subject_name: Gallium Ga 68 NY104

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5856418

object_name: clear cell renal carcinoma


subject: UMLS:C5856418

object_name: renal cell adenocarcinoma


subject: UMLS:C5856418

object_name: renal cell carcinoma


subject: UMLS:C5959689

subject_name: Bcl-2 Inhibitor TGRX-814

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5959689

object_name: acute myeloid leukemia


subject: UMLS:C5959689

object_name: Myelodysplasia


subject: UMLS:C5959689

object_name: adult acute lymphoblastic leukemia


subject: UMLS:C5959689

object_name: non-Hodgkin lymphoma


subject: UMLS:C5959689


subject: UMLS:C5959689


subject: UMLS:C5959689


subject: GTOPDB:5063

subject_name: thrombopoietin

object_name: female reproductive system neoplasm


subject: UNII:5651J3R2JF

subject_name: THROMBOPOIETIN


subject: PUBCHEM.COMPOUND:85540151

object_name: Well adult


subject: MESH:C575982

subject_name: docosahexaenoic acid monoacylglyceride


subject: CHEBI:86465

subject_name: Kalinite

object_name: influenza


subject: UNII:I7T908772F

subject_name: alum


subject: CHEBI:86463

subject_name: Potassium alum


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: lipoid nephrosis


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: high grade B-cell lymphoma


subject: CHEBI:175901

object_name: marginal zone lymphoma


subject: CHEBI:175901

object_name: primary mediastinal large B-cell lymphoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:43805

object_name: follicular lymphoma


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805

object_name: MALT lymphoma


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Chronic allergic conjunctivitis


subject: UMLS:C5206716

object_name: Embolism, Tumor


subject: UMLS:C5206716

object_name: Neoplasm Metastasis


subject: UMLS:C5206716

object_name: Metastasis


subject: UMLS:C5206716

object_name: Metastatic Lesion


subject: UMLS:C4055105

subject_name: EGFR Antibody


subject: UMLS:C4055105


subject: UMLS:C4055105


subject: UMLS:C4055105


subject: UMLS:C5700426

subject_name: furmonertinib

object_name: Malignant Neoplasm of Lung - Multiple Primary Sites


subject: CHEBI:8378

object_name: allergic bronchopulmonary aspergillosis


subject: CHEBI:10023

subject_name: Voriconazole


subject: UNII:834YJF89WO

subject_name: Belumosudil

object_name: interstitial lung disease 1


subject: UNII:834YJF89WO

object_name: interstitial lung disease 2


subject: UMLS:C4330035

subject_name: Gallium Ga 68-NOTA-3PTATE-RGD

object_name: lung cancer


subject: UMLS:C4330035

object_name: lung neoplasm


subject: UMLS:C4330035

object_name: lung carcinoma


subject: UMLS:C4330035

object_name: neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:75905632

subject_name: flavocoxid

object_name: osteoarthritis susceptibility 6


subject: PUBCHEM.COMPOUND:75905632

object_name: osteoarthritis, knee


subject: CHEMBL.COMPOUND:CHEMBL5095276

subject_name: FLAVOCOXID


subject: CHEMBL.COMPOUND:CHEMBL5095276


subject: UMLS:C1616742


subject: UMLS:C1616742


subject: CHEBI:24151

subject_name: galactooligosaccharide

object_name: type 2 diabetes mellitus


subject: CHEBI:24151

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:24151

object_name: obesity


subject: CHEBI:24151

object_name: Obesity, CTCAE


subject: CHEBI:367163

subject_name: Darunavir

object_name: pneumocystosis


subject: CHEBI:367163

object_name: Coronavinae infectious disease


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat


subject: PUBCHEM.COMPOUND:24950485


subject: UMLS:C4742197

object_name: cancer


subject: UMLS:C4742197

object_name: neoplasm


subject: UMLS:C3539881

subject_name: gamma-interferon

object_name: skin melanoma


subject: UMLS:C3539881

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:84500

subject_name: varenicline

object_name: bipolar disorder


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Childhood Malignant Solid Neoplasm


subject: CHEBI:9168

object_name: Malignant Solid Neoplasm


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:77590

subject_name: Armodafinil

object_name: HIV infection


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:2453

subject_name: Acyclovir

object_name: viral pneumonia


subject: CHEBI:465284

subject_name: Ganciclovir


subject: UMLS:C4287711

subject_name: METAP2 inhibitor SDX-7320

object_name: Childhood Breast Carcinoma


subject: UMLS:C4287711

object_name: breast carcinoma


subject: UMLS:C4287711

object_name: breast cancer


subject: PR:000011379

subject_name: atrial natriuretic peptide receptor 3

object_name: intervertebral disk degenerative disorder


subject: UNII:T7K20Y2GWY

subject_name: Corifollitropin alfa

object_name: Subfertility


subject: UMLS:C3252350

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C0721231

object_name: keloid


subject: CHEBI:77733

subject_name: Verapamil


subject: UMLS:C1831763

object_name: prostate cancer


subject: UMLS:C1831763

object_name: prostate neoplasm


subject: MESH:D017077

subject_name: Culture Media, Conditioned

object_name: cerebral palsy


subject: CHEBI:230905

subject_name: Ribociclib

object_name: Postmenopausal


subject: CHEBI:230905

object_name: HER2 positive breast carcinoma


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: periodontitis


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: Reperfusion Injury


subject: CHEBI:168243

object_name: acute kidney failure


subject: CHEBI:168243

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: UNII:6897GXD6OE

object_name: Iron deficiency without anemia


subject: CHEBI:75551


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Adverse effects


subject: GTOPDB:13716

subject_name: disitamab vedotin

object_name: lung cancer


subject: GTOPDB:13716

object_name: lung neoplasm


subject: GTOPDB:13716

object_name: lung carcinoma


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UNII:RB3U3A1S27


subject: UNII:RB3U3A1S27


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: CHEBI:521033

subject_name: Dutasteride

object_name: benign neoplasm


subject: UMLS:C5706561

subject_name: Actinium Ac 225 DOTATATE RYZ101

object_name: Recurrent Meningioma


subject: CHEBI:32551


subject: CHEBI:29967

subject_name: L-lysine residue


subject: CHEBI:133538

subject_name: Lysine


subject: UMLS:C0024337

subject_name: lysine


subject: CHEBI:47426

subject_name: Furosemide

object_name: Pulmonary Complication


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: burning mouth syndrome


subject: CHEBI:31312

subject_name: Bucillamine


subject: UMLS:C2827536

subject_name: DEC-205/NY-ESO-1 Fusion Protein CDX-1401

object_name: non-small cell lung carcinoma


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Fatty Liver


subject: UMLS:C5784960

subject_name: Prodencel

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1

object_name: maturity-onset diabetes of the young type 3


subject: UMLS:C0017132

subject_name: Gastric Inhibitory Polypeptide


subject: CHEBI:5383

subject_name: Glimepiride


subject: CHEBI:30744

subject_name: OXALOACETATE

object_name: amyotrophic lateral sclerosis


subject: UNII:8CXV4OU367

subject_name: Arbidol

object_name: influenza


subject: CHEBI:134730

subject_name: Umifenovir


subject: UMLS:C5399815


subject: PUBCHEM.COMPOUND:21937662

subject_name: Isavuconazole

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:21937662

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:21937662

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:21937662

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:21937662

object_name: leukopenia


subject: PUBCHEM.COMPOUND:21937662

object_name: neutropenia


subject: CHEBI:32060

subject_name: propagermanium

object_name: diabetic kidney disease


subject: UNII:1Q2P9TO9Q7

subject_name: Propagermanium


subject: CHEBI:15891

subject_name: Taurine

object_name: Ambidexterity


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: cholangitis


subject: CHEBI:3515

subject_name: Cefuroxime


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Rhytide of glabellar skin


subject: UNII:897NVD4A52

subject_name: p-Chloroamphetamine

object_name: prostate carcinoma


subject: UNII:897NVD4A52

object_name: prostate cancer


subject: CHEBI:62248


subject: CHEBI:62248


subject: CHEBI:36751


subject: CHEBI:36751


subject: CHEBI:16010


subject: CHEBI:16010


subject: UMLS:C0034330

subject_name: Pidolic acid


subject: UMLS:C0034330


subject: CHEBI:28794

subject_name: Coumarin

object_name: chronic venous insufficiency


subject: CHEBI:91643

subject_name: citrin


subject: UNII:7Y4N11PXO8

subject_name: Troxerutin


subject: CHEBI:63633

subject_name: Triptorelin

object_name: isolated short stature


subject: CHEBI:63633

object_name: Idiopathic short stature


subject: UMLS:C3714249

object_name: intrahepatic cholestasis


subject: CHEBI:16796

subject_name: Melatonin

object_name: Hot Flashes, CTCAE


subject: CHEBI:16796

object_name: Hot flashes


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: Osteosarcoma


subject: CHEBI:229221

object_name: bone sarcoma


subject: CHEBI:229221

object_name: Refractory Neoplasm


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: sickle cell disease


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: graft versus host disease


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:6754

subject_name: Meperidine


subject: CHEBI:6754


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:9570

subject_name: Thiotepa


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: CHEBI:133021

subject_name: Venetoclax

object_name: lymphoplasmacytic lymphoma


subject: UMLS:C5555844

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C5555844

object_name: B-cell neoplasm


subject: CHEBI:49956

subject_name: Xenon

object_name: Hypoxic-Ischemic Encephalopathy


subject: UMLS:C4722545

object_name: Post-Operative Pain


subject: CHEBI:39464

subject_name: (-)-pilocarpine

object_name: Neck Carcinoma


subject: CHEBI:39464

object_name: head and neck neoplasm


subject: CHEBI:39464

object_name: head and neck cancer


subject: CHEBI:39464

object_name: cancer


subject: CHEBI:39464

object_name: neoplasm


subject: CHEBI:8207

subject_name: Pilocarpine


subject: CHEBI:8207


subject: PUBCHEM.COMPOUND:541197

subject_name: Norethindrone acetate

object_name: Simple Ovarian Cyst


subject: CHEBI:7627

subject_name: Norethisterone


subject: GTOPDB:8297

subject_name: seribantumab

object_name: Metastatic malignant neoplasm to pancreas


subject: UNII:1N3L70MDFX


subject: UMLS:C2703144


subject: UNII:7R7G6EH5UL

subject_name: Navtemadlin

object_name: B-cell chronic lymphocytic leukemia


subject: DRUGBANK:DB16471


subject: CHEBI:28834

object_name: familial multiple lipomatosis


subject: CHEBI:28834

object_name: lipoma


subject: UMLS:C2000258

object_name: renal cell carcinoma


subject: UMLS:C2000258

object_name: breast neoplasm


subject: UMLS:C2000258

object_name: T-Cell Lymphoma


subject: UMLS:C2000258

object_name: melanoma


subject: CHEBI:37144

subject_name: epichlorohydrin

object_name: hyperlipidemia


subject: CHEBI:37144

object_name: Dyslipidemia


subject: CHEBI:37144

object_name: cardiovascular disorder


subject: CHEBI:28364

subject_name: Icosapent


subject: CHEBI:28364


subject: CHEBI:28364


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: PR:000016352


subject: PR:000016352


subject: CHEBI:36005

subject_name: docosahexaenoic acid


subject: CHEBI:36005


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:32599

object_name: Intraoperative Hemorrhage


subject: CHEBI:8080

subject_name: Phentermine

object_name: Hepatic impairment


subject: CHEBI:63631

subject_name: Topiramate


subject: UNII:T5W3M0VO9B

object_name: Autoimmunity


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: cancer


subject: CHEBI:2666

object_name: neoplasm


subject: CHEBI:2666

object_name: neuralgia


subject: CHEBI:2666

object_name: Neuralgia, CTCAE


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid


subject: PUBCHEM.COMPOUND:4715169


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:31410

subject_name: clenbuterol hydrochloride

object_name: type 2 diabetes mellitus


subject: CHEBI:174690

subject_name: Clenbuterol


subject: CHEBI:233309

subject_name: Adagrasib

object_name: Resectable non-small cell lung cancer


subject: UMLS:C3826869

subject_name: SOM230 LAR

object_name: ACTH-producing pituitary gland neoplasm


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C2348288


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism


subject: UMLS:C3540792


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:27306


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:176795

subject_name: pyridinium chlorochromate

object_name: Neck Carcinoma


subject: CHEBI:176795

object_name: head and neck neoplasm


subject: CHEBI:176795

object_name: head and neck cancer


subject: UNII:03ZI7ZZW5Q


subject: UNII:03ZI7ZZW5Q


subject: UNII:03ZI7ZZW5Q


subject: UMLS:C4048712

subject_name: factor IX complex


subject: UMLS:C4048712


subject: UMLS:C4048712


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: autosomal dominant polycystic kidney disease


subject: UNII:KXC7811DBY

subject_name: ACOLBIFENE HYDROCHLORIDE

object_name: breast carcinoma


subject: UNII:KXC7811DBY

object_name: lobular breast carcinoma in situ


subject: UNII:KXC7811DBY

object_name: Atypical hyperplasia of breast


subject: UNII:KXC7811DBY

object_name: ductal breast carcinoma in situ


subject: UMLS:C1879543

subject_name: Acolbifene Hydrochloride


subject: UMLS:C1879543


subject: UMLS:C1879543


subject: UMLS:C1879543


subject: UMLS:C4086499

subject_name: Huaier Extract Granule

object_name: liver carcinoma


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: pneumonia


subject: UMLS:C0085297

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:59204

subject_name: Carbetocin

object_name: pregnancy disorder


subject: GTOPDB:9589

subject_name: enoblituzumab

object_name: fallopian tube adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL3545373

subject_name: ENOBLITUZUMAB


subject: UMLS:C3273458


subject: GTOPDB:4985

object_name: peritoneum cancer


subject: GTOPDB:4985


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C1541801

subject_name: TroVax

object_name: castration-resistant prostate carcinoma


subject: UMLS:C5940911


subject: CHEBI:6801

subject_name: Metformin

object_name: hemoglobinopathy


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: Postoperative Complications


subject: UMLS:C1881373

object_name: neoplasm


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: UNII:2GFP9BJD79

subject_name: Glucarpidase

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:2GFP9BJD79

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:2GFP9BJD79

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:2GFP9BJD79

object_name: Childhood Solid Neoplasm


subject: UNII:2GFP9BJD79

object_name: Adult Solid Neoplasm


subject: UNII:2GFP9BJD79

object_name: Solid Neoplasm


subject: CHEBI:32599

object_name: neuralgia


subject: CHEBI:32599

object_name: Neuropathic pain


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: plantar wart


subject: UMLS:C1327844

object_name: Low Grade Squamous Intraepithelial Neoplasia


subject: UMLS:C1327844

object_name: High Grade Squamous Intraepithelial Neoplasia


subject: UMLS:C1327844

object_name: High-Grade Squamous Intraepithelial Lesions


subject: CHEBI:40009

subject_name: Cycloserine

object_name: pyelonephritis


subject: CHEBI:40009

object_name: urinary tract infection


subject: CHEBI:40009

object_name: Recurrent urinary tract infections


subject: PUBCHEM.COMPOUND:44210114

subject_name: Lurasidone


subject: PUBCHEM.COMPOUND:44210114


subject: PUBCHEM.COMPOUND:44210114


subject: PUBCHEM.COMPOUND:71306410

subject_name: Azarga

object_name: ocular hypertension


subject: PUBCHEM.COMPOUND:71306410

object_name: Ocular hypertension


subject: CHEBI:48873

subject_name: cholinergic antagonist

object_name: Postmenopausal symptoms


subject: CHEBI:48873

object_name: Alzheimer disease type 1


subject: CHEBI:48873

object_name: Alzheimer disease


subject: UMLS:C0242897

subject_name: Cholinergic Antagonists


subject: UMLS:C0242897


subject: UMLS:C0242897


subject: UMLS:C3537004

subject_name: Anticholinergic [EPC]


subject: UMLS:C3537004


subject: UMLS:C3537004


subject: CHEBI:193137


subject: UMLS:C2984020


subject: UMLS:C0304229

subject_name: Experimental drug

object_name: common cold


subject: UMLS:C0304229

object_name: Upper Respiratory Infections


subject: UMLS:C0304229

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0304229

object_name: Flu symptoms


subject: UNII:A2VM2V569A

object_name: Brain Lesion


subject: UNII:A2VM2V569A

object_name: metastatic malignant neoplasm in the brain


subject: UNII:A2VM2V569A

object_name: Generalized cancer, primary


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: metastatic colorectal cancer


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: UNII:5YV419FIJS

subject_name: sodium glycididazole


subject: CHEBI:74814

subject_name: Ser-Gly


subject: CHEBI:33351

subject_name: seaborgium atom


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Renal function aggravated


subject: CHEBI:93776

subject_name: Pevonedistat

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: cholecystitis


subject: PUBCHEM.COMPOUND:6096882

object_name: Cholecystitis, CTCAE 3.0


subject: PUBCHEM.COMPOUND:6096882

object_name: Cholecystitis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:6096882

object_name: Biliary colic NOS without mention of cholecystitis


subject: PUBCHEM.COMPOUND:6096882

object_name: cholelithiasis


subject: PUBCHEM.COMPOUND:6096882

object_name: Biliary pancreatitis


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UMLS:C4525627

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C4525627

object_name: COPD, severe early onset


subject: UMLS:C4525627


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: diffuse large B-cell lymphoma


subject: CHEBI:79699

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:79699

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:16108

subject_name: Dihydroxyacetone phosphate


subject: CHEBI:16108


subject: CHEBI:16108


subject: CHEBI:39669

subject_name: Diflunisal

object_name: hereditary amyloidosis


subject: CHEBI:39669

object_name: familial amyloid neuropathy


subject: UMLS:C0593271

subject_name: Gelofusine

object_name: Hemolysis


subject: UMLS:C0593271

object_name: Hemolysis - observation


subject: UMLS:C0593271

object_name: Hemolysis, CTCAE


subject: UMLS:C0593271

object_name: coronary microvascular disorder


subject: UMLS:C0593271

object_name: Fluid Overload


subject: UMLS:C0593271

object_name: Hypervolemia


subject: UMLS:C1875730

subject_name: RINGER'S


subject: UMLS:C1875730


subject: UMLS:C1875730


subject: UMLS:C1875730


subject: UMLS:C1875730


subject: UMLS:C1875730


subject: CHEBI:82960

subject_name: Raltegravir

object_name: hyperlipidemia


subject: CHEBI:82960

object_name: hyperlipoproteinemia


subject: CHEBI:82960

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:82960

object_name: Serum lipids high (finding)


subject: CHEBI:82960

object_name: hypertriglyceridemia


subject: CHEBI:82960

object_name: Hypertriglyceridemia, CTCAE


subject: MESH:C000614959

object_name: Childhood Breast Carcinoma


subject: MESH:C000614959

object_name: breast carcinoma


subject: MESH:C000614959

object_name: breast cancer


subject: MESH:C000614959

object_name: Carcinoma breast stage IV


subject: UMLS:C1744376

object_name: amphetamine abuse


subject: UMLS:C1744376

object_name: substance-related disorder


subject: CHEBI:135925

subject_name: Lisdexamfetamine


subject: CHEBI:135925


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: Bipolar affective disorder, currently depressed, moderate


subject: UMLS:C5854615

subject_name: PD-L1 Inhibitor INCB099280

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5854615

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5854615

object_name: cervical cancer


subject: UMLS:C5854615

object_name: cervical carcinoma


subject: UMLS:C5854615

object_name: nasopharyngeal carcinoma


subject: UMLS:C5854615

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C5854615

object_name: liver carcinoma


subject: UMLS:C5854615

object_name: trabecular adenocarcinoma


subject: UMLS:C5854615

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C5854615

object_name: urothelial carcinoma


subject: UMLS:C5854615

object_name: transitional cell carcinoma


subject: UMLS:C5854615

object_name: Mesothelioma


subject: UMLS:C5854615

object_name: mesothelial neoplasm


subject: UMLS:C5854615

object_name: malignant mesothelioma


subject: MESH:D010955

subject_name: Plasmalogens

object_name: obesity due to melanocortin 4 receptor deficiency


subject: MESH:D010955

object_name: obesity


subject: MESH:D010955

object_name: Obesity, CTCAE


subject: RXCUI:404914

subject_name: Caduet

object_name: abdominal obesity-metabolic syndrome


subject: RXCUI:404914

object_name: metabolic syndrome X


subject: UMLS:C5192901

subject_name: Capsaicin 179 mg cutaneous patch

object_name: coccygodynia


subject: UMLS:C5192901

object_name: Disorder of coccyx


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Uterine hemorrhage


subject: CHEBI:60648

object_name: Uterine Hemorrhage, CTCAE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Hemodynamic stability


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Symptomatic COVID-19 Infection Laboratory-Confirmed


subject: CHEBI:91397

object_name: Asymptomatic COVID-19 Infection Laboratory-Confirmed


subject: CHEBI:52993

subject_name: Lormetazepam

object_name: anxiety


subject: CHEBI:52993

object_name: Anxiety symptoms


subject: CHEBI:52993

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:52993

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:6539

subject_name: Lorazepam


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:125354

subject_name: Plerixafor

object_name: Malignant lymphoma, stem cell type


subject: GTOPDB:4934

subject_name: G-CSF


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UNII:254XY8NV84

object_name: Renal Function


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: pain agnosia


subject: CHEBI:6149

object_name: Pain insensitivity


subject: UMLS:C3864947

subject_name: Gardasil 9

object_name: Human Papilloma Virus, Female


subject: UMLS:C3864947

object_name: Human Papilloma Virus, Male


subject: CHEBI:32297

subject_name: Vinpocetine

object_name: Inflammation


subject: CHEBI:32297

object_name: stroke disorder


subject: CHEBI:32297

object_name: cerebrovascular disorder


subject: CHEBI:32297

object_name: Stroke (heart beat)


subject: CHEBI:32297

object_name: Stroke, CTCAE


subject: CHEBI:91571


subject: CHEBI:91571


subject: CHEBI:91571


subject: CHEBI:91571


subject: CHEBI:91571


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: ISS Stage III Plasma Cell Myeloma


subject: UNII:DPT0O3T46P

object_name: ISS Stage II Plasma Cell Myeloma


subject: UNII:DPT0O3T46P

object_name: ISS Stage I Plasma Cell Myeloma


subject: MESH:D002079

subject_name: Butter

object_name: Heart Disease Risk Factors


subject: DRUGBANK:DB14322

subject_name: Coconut oil


subject: UMLS:C0042438

subject_name: Vegetable Oils


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: pharynx cancer


subject: UNII:2S9ZZM9Q9V

object_name: carcinoma of pharynx


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: UMLS:C3181510

object_name: Drug Interactions


subject: CHEBI:47426

subject_name: Furosemide

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:47426

object_name: pulmonary hypertension


subject: CHEBI:47426

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:47426

object_name: pulmonary arterial hypertension


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: idiopathic aplastic anemia


subject: MESH:C000601880

subject_name: Bonolive

object_name: knee discomfort


subject: MESH:C000601880

object_name: Knee pain


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Common Migraine


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:73604

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:73604

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:73604

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:73604

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:73604

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:36796

subject_name: duloxetine

object_name: colorectal cancer


subject: CHEBI:36796

object_name: colorectal carcinoma


subject: CHEBI:36796

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5666890

subject_name: BTK Degrader BGB-16673

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5666890

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C5666890

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5666890

object_name: mantle cell lymphoma


subject: UMLS:C5666890

object_name: marginal zone lymphoma


subject: UMLS:C5666890

object_name: MALT lymphoma


subject: UMLS:C5666890

object_name: follicular lymphoma


subject: UMLS:C5666890

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5666890

object_name: non-Hodgkin lymphoma


subject: UMLS:C5666890

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C5666890

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:31355

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: CHEBI:31355

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:31355

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:31355

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:31355

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage IVC Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVC Laryngeal Cancer AJCC v8


subject: CHEBI:31355

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVC Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVB Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Squamous cell carcinoma of head and neck metastatic


subject: UNII:6QVL057INT

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UNII:6QVL057INT

object_name: Squamous Cell Carcinoma of Unknown Primary


subject: UNII:6QVL057INT

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: UNII:6QVL057INT

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:6QVL057INT

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UNII:6QVL057INT

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: UNII:6QVL057INT

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UNII:6QVL057INT

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UNII:6QVL057INT

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UNII:6QVL057INT

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UNII:6QVL057INT

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: UNII:6QVL057INT

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: UNII:6QVL057INT

object_name: Stage IVC Hypopharyngeal Carcinoma AJCC v8


subject: UNII:6QVL057INT

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: UNII:6QVL057INT

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: UNII:6QVL057INT

object_name: Stage IVC Laryngeal Cancer AJCC v8


subject: UNII:6QVL057INT

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:6QVL057INT

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: UNII:6QVL057INT

object_name: Stage IVC Lip and Oral Cavity Cancer AJCC v8


subject: UNII:6QVL057INT

object_name: Stage IVB Lip and Oral Cavity Cancer AJCC v8


subject: UNII:6QVL057INT

object_name: Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C4053601

object_name: Squamous cell carcinoma of head and neck metastatic


subject: UMLS:C4053601

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UMLS:C4053601

object_name: Squamous Cell Carcinoma of Unknown Primary


subject: UMLS:C4053601

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: UMLS:C4053601

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UMLS:C4053601

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UMLS:C4053601

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C4053601

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UMLS:C4053601

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UMLS:C4053601

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C4053601

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UMLS:C4053601

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C4053601

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C4053601

object_name: Stage IVC Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C4053601

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C4053601

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: UMLS:C4053601

object_name: Stage IVC Laryngeal Cancer AJCC v8


subject: UMLS:C4053601

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C4053601

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: UMLS:C4053601

object_name: Stage IVC Lip and Oral Cavity Cancer AJCC v8


subject: UMLS:C4053601

object_name: Stage IVB Lip and Oral Cavity Cancer AJCC v8


subject: UMLS:C4053601

object_name: Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Squamous cell carcinoma of head and neck metastatic


subject: CHEBI:45863

object_name: Squamous cell carcinoma of head and neck recurrent


subject: CHEBI:45863

object_name: Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:45863

object_name: Squamous cell carcinoma of the oral cavity recurrent